Edit |   |
---|---|
Antigenic Specificity | KCNQ1 (N-term), 4-33 |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human |
Isotype | n/a |
Format | peptide affinity purified |
Size | 0.08 mL, 0.4 mL |
Concentration | vial concentration: 0.5 |
Applications | Western Blot (WB), ELISA (EIA) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This KCNQ1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 4-33 amino acids from the N-terminal region of human KCNQ1. This gene encodes a voltage-gated potassium channelrequired for the repolarization phase of the cardiac actionpotential. The gene product can form heteromultimers with two otherpotassium channel proteins, KCNE1 and KCNE3. Mutations in this geneare associated with hereditary long QT syndrome (also known asRomano-Ward syndrome), Jervell and Lange-Nielsen syndrome andfamilial atrial fibrillation. The gene is located in a region ofchromosome 11 that contains a number of contiguous genes, which areabnormally imprinted in cancer and the Beckwith-Wiedeman |
Immunogen | n/a |
Other Names | [Potassium voltage-gated channel subfamily KQT member 1; IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1; KQT-like 1; Voltage-gated potassium channel subunit Kv71; KCNQ1; KCNA8; KCNA9; KVLQT1] |
Gene, Accession # | [KCNQ1], Gene ID: 3784, NCBI: NP_000209.2, UniProt: P51787 |
Catalog # | MBS9202228 |
Price | $165, $370 |
Order / More Info | KCNQ1 (N-term), 4-33 Antibody from MYBIOSOURCE INC. |
Product Specific References | Nakajo, K., et al. Proc. Natl. Acad. Sci. U.S.A. 107(44):18862-18867(2010) Ren, X.Q., et al. Am. J. Physiol. Heart Circ. Physiol. 299 (5), H1525-H1534 (2010) : Tester, D.J., et al. Am. J. Cardiol. 106(8):1124-1128(2010) Stuebe, A.M., et al. Am. J. Obstet. Gynecol. 203 (3), 283 (2010) : Mohammad, F., et al. Epigenetics 4(5):277-286(2009) |